Pages that link to "Q33752297"

The following pages link to Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for Human Plasmodium vivax Malaria (Q33752297):

Displaying 45 items.

• Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infection (Q24514949) (← links)
• The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate (Q27618095) (← links)
• Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate (Q27641117) (← links)
• Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the Block 2 region of Plasmodium falciparum merozoite surface protein-1. (Q30651257) (← links)
• Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum (Q33282524) (← links)
• Suppression of Plasmodium cynomolgi in rhesus macaques by coinfection with Babesia microti (Q33675969) (← links)
• Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells (Q33957155) (← links)
• Expression of Babesia equi merozoite antigen 1 in insect cells by recombinant baculovirus and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay (Q33971298) (← links)
• Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant (Q34000050) (← links)
• Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19). (Q34003924) (← links)
• Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli (Q34008897) (← links)
• Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens (Q34401573) (← links)
• Plasmodium vivax malaria vaccine development (Q34462082) (← links)
• Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans? (Q34983659) (← links)
• Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression (Q35143303) (← links)
• Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development (Q35212980) (← links)
• A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions (Q35877857) (← links)
• Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants (Q36531338) (← links)
• Vaccines for viral and parasitic diseases produced with baculovirus vectors (Q36601830) (← links)
• The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax (Q36826946) (← links)
• Plasmodium vivax: who cares? (Q37018632) (← links)
• Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria (Q37072009) (← links)
• The future for blood-stage vaccines against malaria (Q37471465) (← links)
• Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli (Q37523989) (← links)
• Development of vaccines for Plasmodium vivax malaria (Q38597276) (← links)
• Expression, Purification and Characterization of a Recombinant Plasmodium Vivax Thrombospondin Related Adhesive Protein (PvTRAP). (Q39523929) (← links)
• Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii (Q39540836) (← links)
• A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. (Q41942680) (← links)
• Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-1(19). (Q41955368) (← links)
• Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys (Q43013555) (← links)
• Unexpected high circulation of Plasmodium vivax in asymptomatic children from Kédougou, southeastern Senegal (Q47114766) (← links)
• Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli. (Q47664368) (← links)
• Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice (Q47834206) (← links)
• Immune responses to Plasmodium falciparum-merozoite surface protein 1 (MSP1) antigen, II. Induction of parasite-specific immunoglobulin G in unsensitized human B cells after in vitro T-cell priming with MSP119. (Q47851458) (← links)
• Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax (Q47852201) (← links)
• Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species (Q47857319) (← links)
• New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. (Q47878245) (← links)
• Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors (Q47893571) (← links)
• Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments. (Q47921710) (← links)
• Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays (Q47977505) (← links)
• Genetic diversity and natural selection of Plasmodium knowlesi merozoite surface protein 1 paralog gene in Malaysia. (Q55287341) (← links)
• Evaluation of Plasmodium vivax isolates in Thailand using polymorphic markers Plasmodium merozoite surface protein (PvMSP) 1 and PvMSP3 (Q57285883) (← links)
• Within-population genetic diversity and population structure of Plasmodium knowlesi merozoite surface protein 1 gene from geographically distinct regions of Malaysia and Thailand (Q59801108) (← links)
• 2nd meeting on novel adjuvants currently in/close to human clinical testing. World Health Organization-Organization Mondiale de la Santé Fondation Mérieux, Annecy, France, 5-7 June 2000 (Q74092574) (← links)
• Protective Immunity in Mice Immunized With P. vivax MSP119-Based Formulations and Challenged With P. berghei Expressing PvMSP119 (Q90176657) (← links)